Melani Nureka
PENDAHULUAN
Deposit
autoantibodi &
kompleks imun
Periode 2006-2011 :
468 pasien (459 wanita, 9 laki-laki) Rutin
Rawat jalan 295 orang (63,03%) Lost follow kontrol ke
Rawat inap 173 orang (36,97%) up (32,26%) Poli
(59,62%)
Periode
Eksaserbasi
Remisi
Aktivitas
Penyakit SLE
SISTEM IMUN
(bawaan, adaptif)
Progresivitas penyakit,
penyebaran epitope
• Photosensitivity S • Serositis
P
• Arthritis H • Hematologic disorder
A
M • Malar rash
I • Immunologic disorder
N • Neurologic disorder
Gejala-gejala SLE
Painful Joints
Fevers
Swollen Joints
Extreme Fatigue
Skin Rashes
Anemia
Renal
Pluerisy
Facial Rash
Photosensitivity
Hair Loss
Clotting
Raynauds
Seizures
Ulcers
0 10 20 30 40 50 60 70 80 90 100
Presentasi Klinis SLE
Penilaian Penyakit SLE
Disease
Disease Activity Damage
MEX SLEDAI SLICC/ACR
Damage Index
Health Status
Assessment
Pemantauan
Perbandingan Aktivitas
Parameter Penyakit
Aktivitas SLE SLE
Penyakit
• Diagnostic workup
• Damage assessment
Overview of the management of systemic lupus erythematosus -John A Reynolds, Ian N Bruce
Issue 2 (Topical Reviews Series 7) Spring 2013
Penatalaksanaan & Mortalitas
1970-1990s
Methotrexate
Transplantasi organ
1950-1954 Plasmapheresis
Cyclosporine 2011
Kortikosteroid Belimumab
5 year survival , 50% 10 year survival >80%
1960-1970s 2000-2010s
1940-1950 Cyclophosphamide Mycophenolate mofetil
Antimalaria Azathioprine Biologics , Retuximab
‘dialysis’
10 year survival >60%
Improvement in antibiotic
antihypertensive, and antithrombotic
therapies
Adapted from Manzi S ,ACR 2012
RINGKASAN
A B C
Lupus mimickers
Kikuchi-Fujimoto disease
Multiple Sclerosis